Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Zinke

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bone Marrow Transplantation|December 5, 2012
Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasmM Unteregger, A Valentin, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|August 24, 2011
Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignanciesW Zinke-Cerwenka, A Valentin, U Posch, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 5, 2002
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonistM R Hellberg, V L Sallee, M A McLaughlin, et al.
Acta Medica Austriaca|May 20, 2003
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphomaP Mikosch, H J Gallowitsch, W Zinke-Cerwenka, et al.
Diabetes & Metabolism|March 11, 2017
Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemiaF Aberer, S Kremser, J K Mader, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agentsMark R Hellberg, Raymond E Conrow, Najam A Sharif, et al.
Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|July 6, 2017
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Survey of Ophthalmology|September 3, 2002
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonistMark R Hellberg, Marsha A McLaughlin, Naj A Sharif, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bone Marrow Transplantation|December 5, 2012
Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasmM Unteregger, A Valentin, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|August 24, 2011
Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignanciesW Zinke-Cerwenka, A Valentin, U Posch, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 5, 2002
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonistM R Hellberg, V L Sallee, M A McLaughlin, et al.
Acta Medica Austriaca|May 20, 2003
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphomaP Mikosch, H J Gallowitsch, W Zinke-Cerwenka, et al.
Diabetes & Metabolism|March 11, 2017
Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemiaF Aberer, S Kremser, J K Mader, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agentsMark R Hellberg, Raymond E Conrow, Najam A Sharif, et al.
Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Bone Marrow Transplantation|July 6, 2017
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Survey of Ophthalmology|September 3, 2002
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonistMark R Hellberg, Marsha A McLaughlin, Naj A Sharif, et al.
Pageof 2